We are live on ! Find out more

Micro Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
PALI icon
1
Palisade Bio
PALI
$249M
$249M $1.43 6.72%
LXEO icon
2
Lexeo Therapeutics
LXEO
$248M
$248M $3.02 9.42%
ACIU icon
3
AC Immune
ACIU
$248M
$248M $2.49 2.05%
FATE icon
4
Fate Therapeutics
FATE
$247M
$247M $2.06 10.8%
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$246M
$246M $0.9726 2.08%
AMRN icon
6
Amarin Corp
AMRN
$242M
$242M $11.48 0.43%
LFCR icon
7
Lifecore Biomedical
LFCR
$241M
$241M $6.37 0.31%
IMRX icon
8
Immuneering
IMRX
$241M
$241M $3.73 1.91%
IKT icon
9
Inhibikase Therapeutics
IKT
$239M
$239M $1.71 3.64%
GLSI icon
10
Greenwich LifeSciences
GLSI
$238M
$238M $16.24 6.77%
UTMD icon
11
Utah Medical Products
UTMD
$238M
$238M $75.07 0.7%
LYEL icon
12
Lyell Immunopharma
LYEL
$238M
$238M $9.70 10.2%
HITI icon
13
High Tide
HITI
$236M
$236M $2.65 1.15%
ELMD icon
14
Electromed
ELMD
$227M
$227M $27.44 0.15%
SY icon
15
So-Young International
SY
$227M
$227M $2.26 0.44%
IFRX icon
16
InflaRx
IFRX
$227M
$227M $1.54 6.21%
SIGA icon
17
SIGA Technologies
SIGA
$226M
$226M $3.15 0.32%
ZNTL icon
18
Zentalis Pharmaceuticals
ZNTL
$226M
$226M $2.39 3.91%
KROS icon
19
Keros Therapeutics
KROS
$226M
$226M $11.40 3.07%
TLSI icon
20
TriSalus Life Sciences
TLSI
$225M
$225M $3.66 3.68%
AMWL icon
21
American Well
AMWL
$225M
$225M $13.20 7.06%
MGNX icon
22
MacroGenics
MGNX
$222M
$222M $3.49 4.8%
SPOK icon
23
Spok Holdings
SPOK
$221M
$221M $10.55 1.15%
GLAS icon
24
Glass House Brands
GLAS
$221M
$221M $2.34 4.88%
ALEC icon
25
Alector
ALEC
$220M
$220M $1.97 1.03%
1
2 3 4 5

Micro Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 541 micro cap Healthcare stocks — companies in the Healthcare sector with a market cap under $250M — worth a combined $33B.

The largest by market cap are Palisade Bio (PALI) at $249M, Lexeo Therapeutics (LXEO) at $248M and AC Immune (ACIU) at $248M.

Among institutional investors, Glass House Brands (GLAS) drew the most net new fund positions in Q2 2026: 50 funds opened new positions, taking total fund holders up 50 (1,667%) quarter-over-quarter.

  • Combined market cap: $33B across 541 stocks.
  • Micro Cap: market cap under $250M.
  • Largest constituent: Palisade Bio (PALI), $249M market cap.
  • Most net new fund positions in Q2 2026: Glass House Brands (GLAS), +50 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.